Inventor · disambiguated record
Yongbo Hu
Also filed as: HU YONGBO
21 granted patents·13 pending applications·207 citations·filing 2000–2025
95Inventor score
Files withMILLENNIUM PHARM INC10EISAI R&D MAN CO LTD7DANA FARBER CANCER INST INC4TAKEDA PHARMACEUTICALS CO3HIROSE MASAAKI2
Top patents by PatentIndex Score
34 records- 0198US9469651B2Halichondrin B analogsEISAI R&D MAN CO LTD·Filed 2015·Granted Oct 18, 2016·39 cites·2 claims
- 0297US9206194B2Halichondrin B analogsEISAI R&D MAN CO LTD·Filed 2013·Granted Dec 8, 2015·41 cites·7 claims
- 0395US8598373B2Halichondrin B analogsHU YONGBO·Filed 2009·Granted Dec 3, 2013·50 cites·9 claims
- 0494US9695188B2Methods useful in the synthesis of halichondrin B analogsEISAI R&D MAN CO LTD·Filed 2016·Granted Jul 4, 2017·17 cites·14 claims
- 0593US10030032B2Methods useful in the synthesis of halichondrin B analogsEISAI R&D MAN CO LTD·Filed 2017·Granted Jul 24, 2018·13 cites·19 claims
- 0691USRE47797EIntermediates for the preparation of analogs of halichondrin BEISAI R&D MAN CO LTD·Filed 2018·Granted Jan 7, 2020·7 cites·15 claims
- 0791US10450324B2Methods useful in the synthesis of halichondrin B analogsEISAI R&D MAN CO LTD·Filed 2018·Granted Oct 22, 2019·9 cites·17 claims
- 0882US9751854B2Heteroaryls and uses thereofMILLENNIUM PHARM INC·Filed 2016·Granted Sep 5, 2017·3 cites·8 claims
- 0981US9802960B2Heteroaryls and uses thereofMILLENNIUM PHARM INC·Filed 2015·Granted Oct 31, 2017·4 cites·29 claims
- 1080US7799915B2Anilino-pyrimidine analogsWYETH LLC·Filed 2005·Granted Sep 21, 2010·4 cites·59 claims
- 1179US11542293B2Sting modulator compounds, and methods of making and usingTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Jan 3, 2023·1 cites·23 claims
- 1278US8796268B2Heteroaryls and uses thereofFREEZE BRIAN S·Filed 2011·Granted Aug 5, 2014·4 cites·30 claims
- 1378US8796271B2Heteroaryls and uses thereofHIROSE MASAAKI·Filed 2011·Granted Aug 5, 2014·4 cites·48 claims
- 1476US2025262298A1Sting modulator compounds with sulfamate linkages, and methods of making and usingCIAVARRI JEFFREY·Filed 2024·Application pending·0 cites
- 1575US10144742B2Quinoxaline compounds and uses thereofMILLENNIUM PHARM INC·Filed 2015·Granted Dec 4, 2018·3 cites·17 claims
- 1675US7786257B2Signal-1/signal-2 bifunctional peptide inhibitorsUNIV KANSAS·Filed 2000·Granted Aug 31, 2010·6 cites·51 claims
- 1775US2025340534A1Allosteric egfr inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2025·Application pending·0 cites
- 1875US2025340535A1Allosteric egfr inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2025·Application pending·0 cites
- 1973US10202373B2Heteroaryls and uses thereofMILLENNIUM PHARM INC·Filed 2015·Granted Feb 12, 2019·2 cites·15 claims
- 2072US12391671B2Allosteric EGFR inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2022·Granted Aug 19, 2025·0 cites·29 claims
- 2170US12054512B2Sting modulator compounds, and methods of making and usingTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Aug 6, 2024·0 cites·23 claims
- 2261US2021015915A1Sting modulator compounds with sulfamate linkages, and methods of making and usingTAKEDA PHARMACEUTICALS CO·Filed 2019·Application pending·0 cites
- 2361US2015175563A1Heteroaryls and uses thereofMILLENNIUM PHARM INC·Filed 2014·Application pending·0 cites
- 2460US2015175593A1Heteroaryls and uses thereofMILLENNIUM PHARM INC·Filed 2014·Application pending·0 cites
- 2558US2012029213A1Intermediates for the preparation of analogs of halichondrin bAUSTAD BRIAN·Filed 2011·Application pending·0 cites
- 2654US2011172427A1Process for preparing certain cinnamide compoundsEISAI R&D MAN CO LTD·Filed 2009·Application pending·0 cites
- 2752US10538533B2Heteroaryls and uses thereofMILLENNIUM PHARM INC·Filed 2017·Granted Jan 21, 2020·0 cites·23 claims
- 2851US2013165472A1Heteroaryls and uses thereofMILLENNIUM PHARM INC·Filed 2012·Application pending·0 cites
- 2951US2013165483A1Heteroaryls and uses thereofMILLENNIUM PHARM INC·Filed 2012·Application pending·0 cites
- 3051US2013165464A1Heteroaryls and uses thereofMILLENNIUM PHARM INC·Filed 2012·Application pending·0 cites
- 3149US12377080B2Allosteric EGFR inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2020·Granted Aug 5, 2025·0 cites·20 claims
- 3249US2008293712A1Benzo[C][2,7]Naphtyridine Derivatives, Methods of Making Thereof and Methods of Use ThereofWYETH CORP·Filed 2008·Application pending·0 cites
- 3342US2007244140A1Anilino-pyrimidine phenyl and benzothiophene analogsWYETH CORP·Filed 2007·Application pending·0 cites
- 3437US9062038B2Heteroaryls and uses thereofHIROSE MASAAKI·Filed 2011·Granted Jun 23, 2015·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Yongbo Hu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →